Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)

Kyung Dong Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	15,769	11,779	14,553	17,807	15,992
Short-Term Investments	10,155	17,109	445.08	12,000	32,445
Trading Asset Securities	4,989	3,186	30,130	20,236	12,911
Cash & Short-Term Investments	30,913	32,075	45,128	50,043	61,348
Cash Growth	-3.62%	-28.93%	-9.82%	-18.43%	-34.98%
Accounts Receivable	22,932	19,156	24,878	21,084	17,581
Other Receivables	1,398	1,416	591.23	423.74	764.38
Receivables	24,330	20,572	25,469	21,508	18,643
Inventory	44,447	34,535	30,158	29,770	28,926
Prepaid Expenses	550.65	1,141	831.9	865.31	61.61
Other Current Assets	786.85	1,427	1,394	1,022	776.29
Total Current Assets	101,028	89,749	102,981	103,208	109,755
Property, Plant & Equipment	74,796	73,646	95,097	89,880	88,585
Long-Term Investments	69,556	73,947	77,107	68,066	62,646
Other Intangible Assets	5,109	5,689	2,889	2,998	2,194
Long-Term Deferred Tax Assets	2,410	1,557	-	-	-
Long-Term Deferred Charges	3,052	-	-	-	-
Other Long-Term Assets	46,622	48,083	32,403	27,822	28,214
Total Assets	302,873	292,971	310,478	291,974	291,394
Accounts Payable	5,018	4,880	5,657	5,751	3,878
Accrued Expenses	7,845	6,801	1,463	1,496	1,468
Short-Term Debt	38,641	15,015	24,085	153.95	635.87
Current Portion of Leases	29.67	276.64	1,350	1,489	706.64
Current Income Taxes Payable	-	4,743	1,877	2,770	4,742
Current Unearned Revenue	-	-	1.76	-	-
Other Current Liabilities	26,895	27,310	15,693	13,705	14,568
Total Current Liabilities	78,428	59,027	50,127	25,364	25,999
Long-Term Leases	6.96	81.08	1,434	2,686	420.56
Long-Term Deferred Tax Liabilities	-	-	1,045	1,016	826.57
Other Long-Term Liabilities	4,100	5,386	347.25	2,618	1,386
Total Liabilities	82,536	64,494	52,953	31,684	28,632
Common Stock	15,684	15,684	15,684	15,684	15,684
Additional Paid-In Capital	34,100	34,108	34,108	34,219	34,198
Retained Earnings	193,299	198,616	231,800	228,447	227,040
Treasury Stock	-30,133	-28,916	-28,916	-28,166	-22,890
Comprehensive Income & Other	7,110	8,686	4,528	9,637	8,155
Total Common Equity	220,061	228,179	257,204	259,821	262,187
Minority Interest	276.2	298.06	320.83	468.74	575.04
Shareholders' Equity	220,337	228,477	257,525	260,290	262,762
Total Liabilities & Equity	302,873	292,971	310,478	291,974	291,394
Total Debt	38,677	15,373	26,869	4,329	1,763
Net Cash (Debt)	-7,764	16,701	18,259	45,714	59,585
Net Cash Growth	-	-8.53%	-60.06%	-23.28%	-11.15%
Net Cash Per Share	-288.15	615.38	671.07	1660.97	2428.55
Filing Date Shares Outstanding	26.94	27.13	27.13	27.23	27.71
Total Common Shares Outstanding	26.94	27.13	27.13	27.23	27.71
Working Capital	22,599	30,722	52,854	77,844	83,756
Book Value Per Share	8168.01	8409.41	9479.11	9540.40	9461.29
Tangible Book Value	214,952	222,490	254,315	256,823	259,993
Tangible Book Value Per Share	7978.39	8199.75	9372.64	9430.31	9382.13
Land	17,894	17,847	26,002	17,372	17,372
Buildings	70,141	67,935	78,165	58,125	58,124
Machinery	65,901	60,966	60,360	66,259	65,063
Construction In Progress	3,260	4,438	2,565	21,513	21,473

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.